Bipolar Disorder Clinical Trial
Official title:
Project CARE (Community Treatment Adherence at Re-Entry): An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial
The aim of this program of research is to develop and pilot the CARE (Community treatment
Adherence at Re-Entry) program, an adjunctive intervention for incarcerated individuals with
bipolar disorder (BD) transitioning from prison to the community.
The purpose of this proposed project is to establish the feasibility, acceptability, and
preliminary effects of this newly developed intervention on symptom outcomes.
Bipolar disorder (BD) is a serious, disabling, and highly recurrent illness that is
disproportionately represented in the criminal justice system. BD increases risk for several
adverse outcomes for prisoners, including mood instability, suicide attempts, substance use
relapse, and high rates of repeat incarceration. Despite these serious negative consequences,
up to 70% of prisoners with BD do not receive mental health treatment upon prison release.
Lack of engagement in ongoing mental health treatment for BD upon community re-entry
represents one potent factor that perpetuates risk for adverse outcomes, and consequences of
untreated BD (e.g., impulsivity, substance use) may greatly exacerbate difficulties in
establishing stable living conditions (e.g., adequate housing, legal employment) at community
re-entry. Thus, there is a critical need for interventions to facilitate engagement with
treatment for BD during this vulnerable transition.
To that end, the primary aim of this study is to develop and establish the feasibility and
acceptability of the Community treatment Adherence at Re-Entry (CARE) program. CARE is an
innovative intervention that will combine evidence-based cognitive-behavioral, family, and
telephone outreach strategies to promote treatment engagement and improve clinical outcomes
for prisoners with BD during the period of community re-entry. CARE will include 3 individual
and 1 family session, followed by 11 brief telephone contacts for up to 6 months
post-release. Given its moderate intensity, adjunctive nature, use of community mental health
counselors, and use of telephone administration for post-release follow-up, CARE has been
designed with an eye toward community implementation. Its proposed mechanisms of action
(i.e., increasing values-action consistency, enhancing social supports, and linkage to
community treatment services) are further well matched to the practical and clinical needs of
re-entering individuals.
The aim of this research is to conduct a small open trial (n=12) of the CARE intervention.
Assessments will occur at baseline, immediately pre-release, 4 weeks post-release, and 24
weeks post-release (post-treatment). This study will examine the feasibility and
acceptability of CARE (e.g., uptake, adherence to, and completion of the CARE intervention,
satisfaction with the intervention, understanding of intervention principles) and of this
research design. This study will also examine treatment effects (within relevant confidence
intervals) on outcomes (e.g., mood symptoms). Change in potential mechanisms (i.e.,
values-action consistency derived from intervention principles) will be examined.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|